Brazil Drug Delivery Devices Market Size & Outlook
Related Markets
Brazil drug delivery devices market highlights
- The Brazil drug delivery devices market generated a revenue of USD 15,652.0 million in 2025 and is expected to reach USD 28,609.6 million by 2033.
- The Brazil market is expected to grow at a CAGR of 7.9% from 2026 to 2033.
- In terms of segment, inhalers was the largest revenue generating product in 2025.
- Infusion Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Drug delivery devices market data book summary
| Market revenue in 2025 | USD 15,652.0 million |
| Market revenue in 2033 | USD 28,609.6 million |
| Growth rate | 7.9% (CAGR from 2026 to 2033) |
| Largest segment | Inhalers |
| Fastest growing segment | Infusion Pumps |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Inhalers, Nebulizers, Injection Devices, Transdermal Patches, Infusion Pumps, Implants, Topical Delivery System, Oral Delivery System, Occular Delivery System |
| Key market players worldwide | Pfizer Inc, Johnson & Johnson, Roche Holding AG, Novartis AG ADR, Bayer AG, UniQure NV, BD, SiBiono GeneTech |
Other key industry trends
- In terms of revenue, Brazil accounted for 3.4% of the global drug delivery devices market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Latin America, Brazil drug delivery devices market is projected to lead the regional market in terms of revenue in 2033.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 28,609.6 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Drug Delivery Devices Market Scope
Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Terumo Corporation | View profile | 5001-10000 | Tokyo, Tokyo, Japan, Asia | http://www.terumo.co.jp/ |
| Gerresheimer AG ADR | View profile | 11660 | Klaus-Bungert-Strasse 4, Duesseldorf, NW, Germany, 40468 | https://www.gerresheimer.com |
| W.L. Gore & Associates | View profile | 5001-10000 | Newark, New Jersey, United States, North America | http://www.gore.com |
| Teleflex Inc | View profile | 14500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | https://www.teleflex.com |
| Boston Scientific Corp | View profile | 48000 | 300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234 | https://www.bostonscientific.com |
| Stryker Corp | View profile | 52000 | 1941 Stryker Way, Portage, MI, United States, 49002 | https://www.stryker.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Brazil drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug delivery devices market will help companies and investors design strategic landscapes.
Inhalers was the largest segment with a revenue share of 25.15% in 2025. Horizon Databook has segmented the Brazil drug delivery devices market based on inhalers, nebulizers, injection devices, transdermal patches, infusion pumps, implants, topical delivery system, oral delivery system, occular delivery system covering the revenue growth of each sub-segment from 2021 to 2033.
Brazil, the largest economy in Latin America, plays a key role in the growth of the drug delivery devices market. Ranked 124th in the 2020 World Bank's ease of doing business index, Brazil allocates nearly 9.88% of its GDP to healthcare and is actively enhancing its healthcare policies, infrastructure, and regulatory framework.
The growing prevalence of chronic diseases, such as cancer, diabetes, gastrointestinal disorders, and neurological conditions, is driving the demand for advanced drug delivery devices in the country.
For instance, a BMJ study reports that 3.3% of Brazilians aged 65 and older are affected by Parkinsonism, with the number expected to double by 2030.
Additionally, the International Diabetes Federation states that 1 in 10 adults in Brazil is living with diabetes. These trends are anticipated to increase the adoption of drug delivery devices, including self-injection systems, supporting market expansion in the coming years.
Reasons to subscribe to Brazil drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil drug delivery devices market databook
-
Our clientele includes a mix of drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil drug delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into Brazil drug delivery devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil drug delivery devices market size, by product, 2021-2033 (US$M)
Brazil Drug Delivery Devices Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
